OPRA from TRI - Making RBQM simple for all clinical trials

OPRA from TRI includes two easy-to-use core modules: OPRA-RAM (Risk Assessment and Management) and OPRA-CM (Central Monitoring). These can be utilized separately or together to effectively manage all risks, controls, and actions in one place, enabling the proactive identification and mitigation of trial risks. Designed for clinical trial sponsors and contract research organizations (CROs), the platform features a user-friendly interface that enables any user to visualize changes over time, uncover hidden insights, and quickly identify areas of concern. This enables teams to focus attention where it's needed most and take informed, timely action with confidence. OPRA is fully validated and 21 CFR part 11 compliant.